Endometriosis: A high-risk population for major chronic diseases?

Human Reproduction Update

Volumn 21, Issue 4, 2014, Pages 500-516

  Kvaskoff, Marina ^a,b,c,d,e   Mu, Fan ^f   Terry, Kathryn L ^a,f,g   Harris, Holly R ^g,h   Poole, Elizabeth M ^a   Farland, Leslie ^f   Missmer, Stacey A ^a,f,g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h KAROLINSKA INSTITUTE   (Sweden)

Author keywords

asthma; Autoimmune diseases; Cancer; Cardiovascular diseases; Endometriosis

Indexed keywords

ALLERGY; ARTICLE; ASTHMA; ATOPY; AUTOIMMUNE DISEASE; BREAST CANCER; CANCER PROGNOSIS; CANCER RISK; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC INFLAMMATION; COMORBIDITY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENDOMETRIUM CANCER; HIGH RISK POPULATION; HUMAN; NONHODGKIN LYMPHOMA; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; AUTOIMMUNE DISEASES; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; FEMALE; LYMPHOMA, NON-HODGKIN; MELANOMA; OVARIAN NEOPLASMS; PREVALENCE; RISK; WOMEN'S HEALTH;

ASTHMA; AUTOIMMUNE DISEASES; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; ENDOMETRIOSIS; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MELANOMA; OVARIAN NEOPLASMS; PREVALENCE; RISK; WOMEN'S HEALTH;

EID: 84938530327     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmv013     Document Type: Article

References (99)

1. Agic A, Xu H, Altgassen C, Noack F, Wolfler MM, Diedrich K, Friedrich M, Taylor RN, Hornung D. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci 2007;14:486-497.
2. Aguiar FM, Melo SB, Galvao LC, Rosa-e-Silva JC, dos Reis RM, Ferriani RA. Serological testing for celiac disease in women with endometriosis. Apilot study. Clin Exp Obstet Gynecol 2009;36:23-25.
3. Aksoy Y, Sivri N, Karaoz B, Sayin C, Yetkin E. Carotid intima-media thickness: a new marker of patients with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 2014; 175:54-57.
4. Ammendola M, Pietropolli A, Saccucci P, Piccione E, Bottini E, Gloria-Bottini F. Acid phosphatase locus 1 genetic polymorphism, endometriosis, and allergy. Fertil Steril 2008;90:1203-1205.
5. Aris A. Endometriosis-associated ovarian cancer: a ten-year cohort study of women living in the Estrie Region of Quebec, Canada. J Ovarian Res 2010;3:2.
6. Ballweg ML. Overcoming Endometriosis: New Help From the Endometriosis Association. New-York: Congdon & Weed, 1987.
7. Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 2001;12:875-880.
8. Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2014;20:748-758.
9. Bedaiwy MA, Falcone T, Mascha EJ, Casper RF. Genetic polymorphism in the fibrinolytic system and endometriosis. Obstet Gynecol 2006;108:162-168.
10. Bertelsen L, Mellemkjaer L, Frederiksen K, Kjaer SK, Brinton LA, Sakoda LC, van Valkengoed I, Olsen JH. Risk for breast cancer among women with endometriosis. Int J Cancer 2007;120:1372-1375.
11. Bodmer M, Becker C, Meier C, Jick SS, Meier CR. Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol 2011;123:200-204.
12. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R. Atherosclerosis and oxidative stress. Histol Histopathol 2008;23:381-390.
13. Borgfeldt C, Andolf E. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 2004;83:395-400.
14. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;176:572-579.
15. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 2004; 82:405-414.
16. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Althuis MD, Mabie JE, Moghissi KS. Causes of infertility as predictors of subsequent cancer risk. Epidemiology 2005; 16:500-507.
17. Buck Louis GM, Peterson CM, Chen Z, Croughan M, Sundaram R, Stanford J, Varner MW, Kennedy A, Giudice L, Fujimoto VY et al. Bisphenol A and phthalates and endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study. Fertil Steril 2013;100:162-169, e161-162.
18. Buis CC, van Leeuwen FE, Mooij TM, Burger CW. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod 2013;28:3358-3369.
19. Bungum HF, Vestergaard C, Knudsen UB. Endometriosis and type 1 allergies/immediate type hypersensitivity: a systematic review. Eur J Obstet Gynecol Reprod Biol 2014;179:209-215.
20. Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M. Family and personal medical history and risk of meningioma. J Neurosurg 2011; 115:1072-1077.
21. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 2007;56:1251-1262.
22. Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. Clin Cancer Res 2003;9:5142-5144.
23. Du D, Li X. The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis. Int J Clin Exp Med 2013;6:880-889.
24. Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis? Autoimmun Rev 2012;11:806-814.
25. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235-258.
26. Ferrero S, Petrera P, Colombo BM, Navaratnarajah R, Parisi M, Anserini P, Remorgida V, Ragni N. Asthma in women with endometriosis. Hum Reprod 2005; 20:3514-3517.
27. Frisch RE, Wyshak G, Albert LS, Sober AJ. Dysplastic nevi, cutaneous melanoma, and gynecologic disorders. Int J Dermatol 1992;31:331-335.
28. Garry R. Endometriosis: an invasive disease. Gynecol Endosc 2001;10:79-82.
29. Gemmill JA, Stratton P, Cleary SD, Ballweg ML, Sinaii N. Cancers, infections, and endocrine diseases in women with endometriosis. Fertil Steril 2010;94:1627-1631.
30. Gottschau M, Kjaer SK, Jensen A, Munk C, Mellemkjaer L. Risk of canceramong women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol 2015; 136:99-103.
31. Gupta S, Agarwal A, Krajcir N, Alvarez JG. Role of oxidative stress in endometriosis. Reprod Biomed Online 2006;13:126-134.
32. Haan YC, Oudman I, de Lange ME, Timmermans A, Ankum WM, van Montfrans GA, Brewster LM. Hypertension risk in Dutchwomen with symptomatic uterine fibroids. Am J Hypertens 2015;28:487-492.
33. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
34. Heidemann LN, Hartwell D, Heidemann CH, Jochumsen KM. The relation between endometriosis and ovarian cancer-a review. Acta Obstet Gynecol Scand 2014; 93:20-31.
35. Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG. Immune interactions in endometriosis. Expert Rev Clin Immunol 2011;7:611-626.
36. Holly EA, Cress RD, Ahn DK. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 1995;141:943-950.
37. Jess T, Frisch M, Jorgensen KT, Pedersen BV, Nielsen NM. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut 2012;61:1279-1283.
38. Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004;50:3458-3467.
39. Kim HS, Kim TH, Chung HH, Song YS. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer 2014;110:1878-1890.
40. Kinugasa S, Shinohara K, Wakatsuki A. Increased asymmetric dimethylarginine and enhanced inflammation are associated with impaired vascular reactivity in women with endometriosis. Atherosclerosis 2011;219:784-788.
41. Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, Morioka E, Arisawa K, Terao T. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 2007;17:37-43.
42. Koumantakis E, Matalliotakis I, Neonaki M, Froudarakis G, Georgoulias V. Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls. Arch Gynecol Obstet 1994;255:107-112.
43. Kvaskoff M, Mesrine S, Fournier A, Boutron-Ruault MC, Clavel-Chapelon F. Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women. Arch Intern Med 2007;167:2061-2065.
44. Lamb K, Nichols TR. Endometriosis: a comparison of associated disease histories. Am J Prev Med 1986;2:324-329.
45. Macut D, Antic IB, Bjekic-Macut J. Cardiovascular risk factors and events inwomen with androgen excess. J Endocrinol Invest 2014. [Epub ahead of print].
46. Matalliotakis I, Cakmak H, Matalliotakis M, Kappou D, Arici A. High rate of allergies among women with endometriosis. J Obstet Gynaecol 2012;32:291-293.
47. Matorras R, Ocerin I, Unamuno M, Nieto A, Peiro E, Burgos J, Exposito A. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome. Lupus 2007;16:736-740.
48. Matta JL, Flores I, Morales LM, Monteiro J, Alvarez-Garriga C, Bayona M. Women with endometriosis have a higher DNA repair capacity and diminished breast cancer risk. Mol Cancer Biol 2013;1.
49. Melin A, Sparen P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006;21:1237-1242.
50. Melin A, Sparen P, Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007;22:3021-3026.
51. Melo AS, Rosa-e-Silva JC, Rosa-e-Silva AC, Poli-Neto OB, Ferriani RA, Vieira CS. Unfavorable lipid profile in women with endometriosis. Fertil Steril 2010; 93:2433-2436.
52. Merritt MA, Green AC, Nagle CM, Webb PM. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 2008;122:170-176.
53. Missmer SA. Commentary: Endometriosis-epidemiologic considerations for a potentially 'high-risk' population. Int J Epidemiol 2009;38:1154-1155.
54. Missmer SA, Cramer DW. The epidemiology of endometriosis. Obstet Gynecol Clin North Am 2003;30:1-19, vii.
55. Missmer SA, Chavarro JE, Malspeis S, Bertone-Johnson ER, Hornstein MD, Spiegelman D, Barbieri RL, Willett WC, Hankinson SE. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod 2010; 25:1528-1535.
56. Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol 2004; 191:733-740.
57. Montgomery GW, Nyholt DR, Zhao ZZ, Treloar SA, Painter JN, Missmer SA, Kennedy SH, Zondervan KT. The search for genes contributing to endometriosis risk. Hum Reprod Update 2008;14:447-457.
58. Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 1993; 22:1000-1009.
59. Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC. Endometrioid and clear cell ovarian cancers: acomparative analysis of risk factors. Eur J Cancer 2008; 44:2477-2484.
60. Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, Morgan M, Schlesselman JJ. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000;11:111-117.
61. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, Wu AH. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002;155:217-224.
62. Nichols TR, Lamb K, Arkins JA. The association of atopic diseases with endometriosis. Ann Allergy 1987;59:360-363.
63. Nielsen NM, Jorgensen KT, Pedersen BV, Rostgaard K, Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Hum Reprod 2011;26:1555-1559.
64. Nnoaham KE, Hummelshoj L, Webster P, d'Hooghe T, de Cicco Nardone F, de Cicco Nardone C, Jenkinson C, Kennedy SH, Zondervan KT. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 2011;96:366-373.
65. Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001; 76:223-231.
66. Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study. Cancer 2002;94:1612-1618.
67. Ott J, Kurz C, Braun R, Promberger R, Seemann R, Vytiska-Binstorfer E, Walch K. Overt hypothyroidism is associated with the presence of uterine leiomyoma: a retrospective analysis. Eur J Obstet Gynecol Reprod Biol 2014;177:19-22.
68. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012;13:385-394.
69. Pennell LM, Galligan CL, Fish EN. Sex affects immunity. J Autoimmun 2012; 38:J282-J291.
70. Petta CA, Arruda MS, Zantut-Wittmann DE, Benetti-Pinto CL. Thyroid autoimmunity and thyroid dysfunction in women with endometriosis. Hum Reprod 2007; 22:2693-2697.
71. Pizzo A, Salmeri FM, Ardita FV, Sofo V, Tripepi M, Marsico S. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest 2002;54:82-87.
72. Porpora MG, Resta S, Fuggetta E, Storelli P, Megiorni F, Manganaro L, DeFelip E. Role of environmental organochlorinated pollutants in the development of endometriosis. Clin Exp Obstet Gynecol 2013;40:565-567.
73. Pretta S, Remorgida V, Abbamonte LH, Anserini P, Ragni N, Del Sette M, Gandolfo C, Ferrero S. Atherosclerosis in women with endometriosis. Eur J Obstet Gynecol Reprod Biol 2007;132:226-231.
74. Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012;38:J109-J119.
75. Rahmioglu N, Nyholt DR, Morris AP, Missmer SA, Montgomery GW, Zondervan KT. Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets. Hum Reprod Update 2014;20:702-716.
76. Roeters van Lennep JE, Heida KY, Bots ML, Hoek A; on behalf of the collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol 2014. [Epub ahead of print].
77. Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control 2008;19:1357-1364.
78. Sampson JA. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg 1925;10:1-72.
79. Santoro L, D'Onofrio F, Campo S, Ferraro PM, Tondi P, Campo V, Flex A, Gasbarrini A, Santoliquido A. Endothelial dysfunction but not increased carotid intima-media thickness in young European women with endometriosis. Hum Reprod 2012; 27:1320-1326.
80. Santoro L, Campo S, D'Onofrio F, Gallo A, Covino M, Campo V, Palombini G, Santoliquido A, Gasbarrini G, Montalto M. Looking for celiac disease in Italian womenwith endometriosis: a case control study. Biomed Res Int 2014;2014:236821.
81. Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 1997;70:150-154.
82. Simoens S, Hummelshoj L, Dunselman G, Brandes I, Dirksen C, D'Hooghe T. Endometriosis cost assessment (the Endo Cost study): a cost-of-illness study protocol. Gynecol Obstet Invest 2011a;71:170-176.
83. Simoens S, Meuleman C, D'Hooghe T. Non-health-care costs associated with endometriosis. Hum Reprod 2011b;26:2363-2367.
84. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002; 17:2715-2724.
85. Somigliana E, Vigano P, Parazzini F, Stoppelli S, Giambattista E, Vercellini P. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol 2006; 101:331-341.
86. Stephansson O, Falconer H, Ludvigsson JF. Risk of endometriosis in 11,000womenwith celiac disease. Hum Reprod 2011;26:2896-2901.
87. Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 2003;79:1288-1293.
88. Tiniakou E, Costenbader KH, Kriegel MA. Sex-specific environmental influences on the development of autoimmune diseases. Clin Immunol 2013;149:182-191.
89. Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril 2002;77:861-870.
90. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586-1590.
91. Vigano P, Somigliana E, Panina P, Rabellotti E, Vercellini P, Candiani M. Principles of phenomics in endometriosis. Hum Reprod Update 2012;18:248-259.
92. Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 1999;28:816-823.
93. Wu MH, Yang BC, Hsu CC, Lee YC, Huang KE. The expression of soluble intercellular adhesion molecule-1 in endometriosis. Fertil Steril 1998;70:1139-1142.
94. Wu X, Cai H, Kallianpur A, Li H, Yang G, Gao J, Xiang YB, Ji BT, Yu T, Zheng W et al. Impact of premature ovarian failure on mortality and morbidity among Chinese women. PLoS One 2014;9:e89597.
95. Wyshak G, Frisch RE. Red hair color, melanoma, and endometriosis: suggestive associations. Int J Dermatol 2000;39:798.
96. Wyshak G, Frisch RE, Albright NL, Albright TE, Schiff I. Reproductive factors and melanoma of the skin among women. Int J Dermatol 1989;28:527-530.
97. Young P, Purdie D, Jackman L, Molloy D, Green A. A study of infertility treatment and melanoma. Melanoma Res 2001;11:535-541.
98. Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 2002; 17:1415-1423.
99. Zucchetto A, Serraino D, Polesel J, Negri E, De Paoli A, Dal Maso L, Montella M, La Vecchia C, Franceschi S, Talamini R. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev 2009;18:316-321.